| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
102,087,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
3,941,702 |
Avg
Vol: |
1,803,464 |
| 52
Week Range: |
$45.85 - $45.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jensen James U |
VP, Corp Dev and Legal Affairs |
• – – |
2003-12-15 |
4 |
S |
$31.53 |
$63,053 |
I/I |
(2,000) |
0 |
|
- |
|
| Parrish Stephen R |
VP, Manufacturing |
• – – |
2003-12-10 |
4 |
S |
$31.55 |
$419,741 |
D/D |
(13,304) |
0 |
|
- |
|
| Parrish Stephen R |
VP, Manufacturing |
• – – |
2003-12-10 |
4 |
OE |
$17.83 |
$228,224 |
D/D |
12,800 |
13,304 |
|
- |
|
| Clark David L |
VP, Operations |
• – – |
2003-12-08 |
4 |
S |
$30.50 |
$36,600 |
D/D |
(1,200) |
3,390 |
|
- |
|
| Clark David L |
VP, Operations |
• – – |
2003-12-08 |
4 |
OE |
$4.50 |
$26,900 |
D/D |
3,200 |
4,590 |
|
- |
|
| Klein Joseph III |
Director |
– • – |
2003-12-02 |
4 |
AS |
$31.20 |
$62,409 |
D/D |
(2,000) |
0 |
|
- |
|
| Klein Joseph III |
Director |
– • – |
2003-12-02 |
4 |
OE |
$7.25 |
$14,500 |
D/D |
2,000 |
2,000 |
|
- |
|
| Kuhla Donald E |
Director |
– • – |
2003-12-02 |
4 |
S |
$31.02 |
$155,100 |
D/D |
(5,000) |
33,500 |
|
- |
|
| Jensen James U |
VP, Corp Dev and Legal Affairs |
• – – |
2003-12-02 |
4 |
AS |
$31.35 |
$128,899 |
D/D |
(4,112) |
23,004 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2003-12-01 |
4 |
AS |
$29.92 |
$89,754 |
D/D |
(3,000) |
12,033 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2003-12-01 |
4 |
OE |
$4.50 |
$19,025 |
D/D |
3,000 |
15,033 |
|
- |
|
| Jackson Hunter |
President, CEO and Chairman |
• • – |
2003-12-01 |
4 |
AS |
$29.99 |
$49,969 |
D/D |
(1,666) |
34,146 |
|
- |
|
| Jackson Hunter |
President, CEO and Chairman |
• • – |
2003-12-01 |
4 |
AS |
$29.98 |
$124,920 |
I/I |
(4,166) |
32,502 |
|
- |
|
| Parks Thomas N |
Director |
– • – |
2003-12-01 |
4 |
AS |
$29.99 |
$114,430 |
I/I |
(3,776) |
30,560 |
|
- |
|
| Jensen James U |
VP, Corp Dev and Legal Affairs |
• – – |
2003-12-01 |
4 |
AS |
$31.32 |
$43,848 |
D/D |
(1,400) |
27,116 |
|
- |
|
| Jackson Hunter |
President, CEO and Chairman |
• • – |
2003-11-25 |
4 |
S |
$30.00 |
$150,000 |
D/D |
(5,000) |
35,812 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2003-11-24 |
4 |
S |
$29.81 |
$298,078 |
D/D |
(10,000) |
12,033 |
|
- |
|
| Marriott Thomas B III |
VP, Development Research |
• – – |
2003-11-24 |
4 |
OE |
$3.00 |
$30,000 |
D/D |
10,000 |
22,033 |
|
- |
|
| Groninger James G |
Director |
– • – |
2003-11-24 |
4 |
S |
$29.48 |
$54,538 |
D/D |
(1,850) |
21,298 |
|
- |
|
| Mueller Alan L |
VP, Drug Discovery |
• – – |
2003-11-21 |
4 |
S |
$29.09 |
$87,270 |
I/I |
(3,000) |
14,516 |
|
- |
|
| Clark David L |
VP, Operations |
• – – |
2003-11-21 |
4 |
GA |
$0.00 |
$0 |
D/D |
1,941 |
1,390 |
|
- |
|
| Groninger James G |
Director |
– • – |
2003-11-21 |
4 |
S |
$29.11 |
$62,878 |
D/D |
(2,160) |
23,178 |
|
- |
|
| Groninger James G |
Director |
– • – |
2003-11-21 |
4 |
OE |
$5.50 |
$18,968 |
D/D |
2,160 |
25,338 |
|
- |
|
| Jensen James U |
VP, Corp Dev and Legal Affairs |
• – – |
2003-11-21 |
4 |
AS |
$29.12 |
$40,761 |
D/D |
(1,400) |
28,516 |
|
- |
|
| Jensen James U |
VP, Corp Dev and Legal Affairs |
• – – |
2003-11-20 |
4 |
AS |
$28.80 |
$55,526 |
D/D |
(1,928) |
29,916 |
|
- |
|
574 Records found
|
|
Page 19 of 23 |
|
|
